Literature DB >> 7672465

Lorazepam versus diazepam in the acute treatment of epileptic seizures and status epilepticus.

R Appleton1, A Sweeney, I Choonara, J Robson, E Molyneux.   

Abstract

Lorazepam was compared with diazepam for the treatment of acute convulsions and status epilepticus in 102 children in a prospective, open, 'odd and even dates' trial. Convulsions were controlled in 76 per cent of patients treated with a single dose of lorazepam and 51 per cent of patients treated with a single dose of diazepam. Significantly fewer patients treated with lorazepam required additional anticonvulsants to terminate the seizure. Respiratory depression occurred in 3 per cent of lorazepam-treated patients and 15 per cent of diazepam-treated patients. No patient who received lorazepam required admission to the intensive care unit for either respiratory depression or persisting status epilepticus. Rectally administered lorazepam appeared to be particularly valuable (100 per cent efficacy) when venous access was not possible.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7672465     DOI: 10.1111/j.1469-8749.1995.tb15014.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  34 in total

Review 1.  Drug trials in children: problems and the way forward.

Authors:  S Conroy; J McIntyre; I Choonara; T Stephenson
Journal:  Br J Clin Pharmacol       Date:  2000-02       Impact factor: 4.335

Review 2.  Status epilepticus: an evidence based guide.

Authors:  Matthew Walker
Journal:  BMJ       Date:  2005-09-24

Review 3.  Best evidence topic reports. Lorazepam or diazepam in paediatric status epilepticus.

Authors:  Vince Choudhery; Will Townend
Journal:  Emerg Med J       Date:  2006-06       Impact factor: 2.740

4.  Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society.

Authors:  Tracy Glauser; Shlomo Shinnar; David Gloss; Brian Alldredge; Ravindra Arya; Jacquelyn Bainbridge; Mary Bare; Thomas Bleck; W Edwin Dodson; Lisa Garrity; Andy Jagoda; Daniel Lowenstein; John Pellock; James Riviello; Edward Sloan; David M Treiman
Journal:  Epilepsy Curr       Date:  2016 Jan-Feb       Impact factor: 7.500

Review 5.  Emergency treatment of acute seizures and status epilepticus.

Authors:  R C Tasker
Journal:  Arch Dis Child       Date:  1998-07       Impact factor: 3.791

6.  Pharmacokinetics of intravenous lorazepam in pediatric patients with and without status epilepticus.

Authors:  James M Chamberlain; Edmund V Capparelli; Kathleen M Brown; Cheryl W Vance; Kathleen Lillis; Prashant Mahajan; Richard Lichenstein; Rachel M Stanley; Colleen O Davis; Stephen Gordon; Jill M Baren; John N van den Anker
Journal:  J Pediatr       Date:  2011-11-01       Impact factor: 4.406

Review 7.  Refractory generalised convulsive status epilepticus : a guide to treatment.

Authors:  Reetta Kälviäinen; Kai Eriksson; Ilkka Parviainen
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

8.  Challenges in the design and analysis of non-inferiority trials: a case study.

Authors:  Valerie Durkalski; Robert Silbergleit; Daniel Lowenstein
Journal:  Clin Trials       Date:  2011-09-15       Impact factor: 2.486

9.  Emergency management of the paediatric patient with generalized convulsive status epilepticus.

Authors:  Jn Friedman
Journal:  Paediatr Child Health       Date:  2011-02       Impact factor: 2.253

Review 10.  Safety of Diastat, a rectal gel formulation of diazepam for acute seizure treatment.

Authors:  John M Pellock
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.